Eli Lilly and Company's Fiscal Year is From January To December - All Figures are in USD, Billions.
The item "Total-Long-Term-Liabilities" stands at 50.94 Billion United States Dollars as of 09/30/2025, the highest value at least since 03/31/2011, the period currently displayed.
As of the end of Eli Lilly and Company's third quarter, the item "Total Long Term Liabilities" stands at 50.94 Billion USD. This represents an increase of 16.97 percent compared to it's value at the end of it's second quarter .
Regarding the One-Year-Change of the series, the current value constitutes an increase of 39.14 percent compared to the value the year prior.
The 1 year change in percent is 39.14.
The 3 year change in percent is 135.38.
The 5 year change in percent is 88.87.
The 10 year change in percent is 299.23.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Johnson & Johnson - Total Long Term Liabilities | 486,508,953,600.00 |
![]() | AbbVie Inc - Total Long Term Liabilities | 399,570,305,024.00 |
![]() | Roche Holding AG - Total Long Term Liabilities | 317,433,206,677.55 |
![]() | AstraZeneca PLC - Total Long Term Liabilities | 280,205,508,085.11 |
![]() | Novartis AG - Total Long Term Liabilities | 255,096,620,580.91 |